Blue Buffalo pledges US$200,000 matching donations for pet cancer research

UNITED STATES – Blue Buffalo, a General Mills pet food brand, will match donations to Morris Animal Foundation up to US$200,000 through 31 December 2026 to support research into cancer detection and treatment in dogs and cats.

Announced ahead of National Pet Cancer Awareness Month in November, the dollar-for-dollar matching programme aims to increase funding for studies addressing serious diseases affecting companion animals.

Morris Animal Foundation is a nonprofit organisation that funds animal health research worldwide.

Blue Buffalo’s partnership with the foundation spans nearly 20 years and has contributed more than US$9 million towards research into conditions affecting pets, including cancer.

The partnership was inspired by the Bishop family’s Airedale, Blue, who was diagnosed with cancer. The experience helped shape the brand’s commitment to pet health.

“Blue Buffalo was founded on the belief that pets are family, and we know how much every moment with them matters,” said Gabriel Viñas, vice president and business unit director for Blue Buffalo Dog at General Mills.

“Blue’s battle with cancer helped inspire our brand, and that continues to drive our commitment to pet health.

By matching donations to Morris Animal Foundation, we’re giving pet parents an opportunity to make an even greater impact on research that could help families enjoy more time with the pets they love,” he said.

Research targets earlier cancer detection and treatment

Among the projects supported by Blue Buffalo is the Golden Retriever Lifetime Study, which follows thousands of dogs throughout their lives. 

The study has collected more than 650,000 biological samples and 75 million data points to help researchers investigate cancer and other health conditions.

Other funded research includes work at Tufts University examining potential treatments for canine bone cancer. 

A collaboration involving Cornell University, Purdue University and Virginia Tech is investigating ways to improve the diagnosis of inflammatory bowel disease and intestinal lymphoma in cats.

Scientists are also exploring whether artificial intelligence can identify early signs of certain cancers, including lymphoma, by analysing DNA fragments in blood samples.

“Understanding cancer starts with understanding how it develops, and that requires studying animals over time,” said Dr Kelly Diehl, senior director of scientific programmes at Morris Animal Foundation.

“The Golden Retriever Lifetime Study is giving scientists an extraordinary resource to explore questions that could ultimately improve how we detect and treat cancer.

We’re grateful for Blue Buffalo’s two decades of support and for the pet parents who help make this important research possible,” she said.

The donation-matching programme will run until 31 December 2026, with contributions matched up to the US$200,000 limit.

Sign up HERE to receive our email newsletters with the latest news updates and insights from Africa and the World, and follow us on our WhatsApp channel for updates.